A Review of endoscopic scoring systems and their importance in a "treat to target" approach in inflammatory bowel disease (with videos).
Endoscopic assessment is currently the criterion standard for the diagnosis and assessment of mucosal disease activity, prognosis and monitoring for dysplasia and the assessment of response to therapy. Wider appreciation of the potential disconnect between symptoms and objective measures of disease activity and evidence that uncontrolled inflammation may lead to progressive intestinal injury and irreversible bowel damage with adverse events, has led to the concept of "treating to target." "Treating to target" is defined as treating patients with high risk for disease progression early to prevent or limit intestinal injury or disability. Endoscopic remission (mucosal healing) has emerged as a key goal of therapy. Although there are no currently validated definitions of endoscopic mucosal remission, the use of endoscopic scoring systems add uniformity, objectivity and aid standardization with reporting of mucosal appearances, augmenting clinical decision-making. A plethora of scoring systems exist to define activity, response and remission in both Crohn's disease and ulcerative colitis. In this review, we discuss the most commonly used endoscopic scoring systems, proposed definitions of response and remission and discuss how they can be integrated into a treat-to target approach to optimize patient outcomes.